Cell & Gene: The Podcast
Cell & Gene, the most valuable online resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, introduces Cell & Gene: The Podcast. In each episode, Cell & Gene Chief Editor, Erin Harris, will talk to industry and academic leaders about their current initiatives and how they are moving the sector forward.
- Update frequency
- every 13 days
- Average duration
- 25 minutes
- Episodes
- 116
- Years Active
- 2021 - 2025
Engineering Off-the-Shelf Cell Therapies for Cancer & Autoimmune Disease with Ernexa Therapeutics' Sanjeev Luther
We love to hear from our listeners. Send us a message.
On episode 111 of Cell & Gene: The Podcast, Host Erin Harris talks to Ernexa Therapeutics' President and CEO, Sanjeev Luther, about how the compa…
What Changes to FDA and CBER Mean for the Future of CGT with Daniela Drago
We love to hear from our listeners. Send us a message.
This is Episode 4 of "FDA Fridays," a special series from Cell & Gene: The Podcast, Chief Editor Erin Harris speaks with regulatory affairs exper…
Inside CRISPR-GPT with Yuanhao Qu
We love to hear from our listeners. Send us a message.
In this episode of Cell & Gene Podcast episode, Host Erin Harris talks to Stanford School of Medicine Ph.D. student, Yuanhao Qu, about his work d…
Barriers, Breakthroughs, and Building Access in Pediatric CGTs with Bambi Grilley, Ph.D.
We love to hear from our listeners. Send us a message.
This is Episode 3 of "FDA Fridays," a 4-week special series from Cell & Gene: The Podcast. Host Erin Harris talks to Bambi Grilley, Ph.D., Profes…
Defining Product Roles and Navigating FDA Approval with Monika Swietlicka
We love to hear from our listeners. Send us a message.
Episode 2 of FDA Fridays, the special series from Cell & Gene: The Podcast, features Host Erin Harris' discussion with regulatory expert Monika S…
Advancing Gene Therapy for FTD with Passage Bio's Dr. Will Chou
We love to hear from our listeners. Send us a message.
In Episode 109 of Cell & Gene: The Podcast, Host Erin Harris talks to Will Chou, M.D., CEO of Passage Bio about the promise and challenges of dev…
FDA Fridays: Advancing Communication and Consistency in CGT Regulation with Kaye Spratt
We love to hear from our listeners. Send us a message.
This is Episode 1 of a special series of Cell & Gene: The Podcast, "FDA Fridays." This first episode features Host, Erin Harris' conversation wit…
Navigating the Journey to Safer Stem Cell Therapies with Orca Bio's Nate Fernhoff
We love to hear from our listeners. Send us a message.
Cell & Gene: The Podcast Host, Erin Harris, talks to Orca Bio CEO and Co-Founder Nathaniel Fernhoff as he recounts the company’s origins and evol…
Rethinking Large Animal Models in Gene Therapy with Novartis' Ralf Schmid, Ph.D.
We love to hear from our listeners. Send us a message.
On this episode of Cell & Gene: The Podcast, Host Erin Harris talks to Ralf Schmid, Ph.D., Associate Director of Preclinical Research at Novartis…
Gene Therapy for Inherited Retinal Diseases with Opus Genetics' Dr. George Magrath
We love to hear from our listeners. Send us a message.
In this episode of Cell & Gene: The Podcast, George Magrath, CEO of Opus Genetics, shares with Host, Erin Harris, how the company is advancing ge…
Extracellular Vesicle Breakthroughs with Aegle Therapeutics' Dr. Gloria Matthews
We love to hear from our listeners. Send us a message.
In this episode of Cell & Gene: The Podcast, Host Erin Harris interviews Dr. Gloria Matthews, Chief Medical Officer of Aegle Therapeutics, a clin…
Bridging Development and Regulation in CGT with Halloran Consulting Group's Monika Swietlicka
We love to hear from our listeners. Send us a message.
On this episode of Cell & Gene: The Podcast, Host Erin Harris welcomes Monika Swietlicka, Principal, Regulatory Strategy at Halloran Consulting G…
Harnessing AI and Synthetic Biology for Cell Therapies with Generate:Biomedicines' Dr. Alex Snyder
We love to hear from our listeners. Send us a message.
Host Erin Harris talks to Generate:Biomedicines' EVP of R&D, Dr. Alex Snyder about the convergence of AI, machine learning (ML), and synthetic bi…
Redefining Heart Failure Treatment with Precision Autologous Cell Therapy with BioCardia's Peter Altman, Ph.D.
We love to hear from our listeners. Send us a message.
In this episode of Cell & Gene: The Podcast, Host Erin Harris sits down with Peter Altman, Ph.D., CEO of BioCardia, to discuss the company’s evol…
CRI’s Response to NIH Cuts with Alicia Zhou, Ph.D.
We love to hear from our listeners. Send us a message.
In this episode of the Cell & Gene podcast, Host Erin Harris speaks with Alicia Zhou, Ph.D., CEO of the Cancer Research Institute (CRI), about CR…
Rethinking CGT Biotech Growth & Investment with Audrey Greenberg
We love to hear from our listeners. Send us a message.
On the 100th episode of Cell & Gene: The Podcast, Host, Erin Harris, sits down with Audrey Greenberg, Founder and CEO of AG Capital Advisors. Aud…
Advancing Retinal Gene Therapy with Atsena Therapeutics' Dr. Kenji Fujita
We love to hear from our listeners. Send us a message.
In this episode of Cell & Gene: The Podcast, Host Erin Harris dives into the world of retinal gene therapy with Kenji Fujita, M.D., Chief Medical…
Harnessing the Power of Cord Blood Tregs with Cellenkos' Dr. Simrit Parmar
We love to hear from our listeners. Send us a message.
In this episode, Host Erin Harris sits down with Dr. Simrit Parmar, Founder of Cellenkos, to explore how the company is pioneering umbilical cord…
CGT Manufacturing: Distributed & Digital with Deloitte Consulting's Omkar Kawalekar, Ph.D.
We love to hear from our listeners. Send us a message.
Omkar Kawalekar, Ph.D., Senior Manager, NextGen Therapies Manufacturing & Supply Chain Lead, Deloitte Consulting joins Host Erin Harris to share …
Inside Gene Therapies for Cardiac Care with Tenaya Therapeutics' Faraz Ali
We love to hear from our listeners. Send us a message.
In this episode, Erin Harris sits down with Faraz Ali, CEO of Tenaya Therapeutics, to explore the cutting-edge world of gene therapies for heart …